Free Newsletter
| Get the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Sign up for free today! |
India surges to lead in generics
More proof that India is the new headwaters of generic drug-making: Watson Pharmaceuticals got the FDA to sign off on its production facility in Goa, India.
The California-based company didn't say which product or products it plans to make there, but did project that, by early 2008, it will be on pace to turn out 1 billion tablets and capsules there annually--all for sale on the U.S. market.
- check out the release on the new facility
- here's more from Forbes
Related Articles:
China now leads India in ongoing clinical trials. Report
Generic competition slashes prices. Report
India's biotech future is bright. Report
Be the first to comment
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
